Search results
Zantac not a cause of woman’s cancer, jury says in first trial over drug
KFGO· 15 hours agoBy Diana Novak Jones CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s...
Corporate deconglomeration is having a moment - Marketplace
Marketplace· 12 hours agoLast month, it was General Electric that split into three companies. There’s been a fair amount of...
German drug discovery company Evotec reports loss in 'challenging' Q1
dpa international via Yahoo Finance· 2 days agoGerman pharmaceutical company Evotec reported a "challenging" first quarter as it revealed a loss...
Alleged drug dealer charged with murdering Sarah Tillman pleads not guilty
KRON via Yahoo News· 15 hours ago(KRON) — A Bay Area man pleaded not guilty to first-degree murder on Wednesday in connection to the...
Panel recommends blood test to detect colon cancer for FDA approval
United Press International via Yahoo News· 8 hours agoA panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new...
'Facebook probably knows I sell drugs'—how young people's digital footprints can threaten their...
Phys.org· 16 hours agoThis trend is particularly popular among young people, who are often involved in trading...
UFC: Khalil Rountree failed drug test due to supplement company’s mistake, suspension reduced to 2...
MMA Junkie via Yahoo Sports· 2 days agoAnti-Doping (CSAD) announced Wednesday. Rountree was first to announce his drug test failure and...
Former trucking company owner, a Sinaloa Cartel member, sentenced with others for drug trafficking -...
The Trucker· 4 days agoSeven members of the Sinaloa Cartel, including one who operated a trucking company, have been...
Skyrocketing diabetes medication costs force life-and-death decisions for patients
WAGA fox local articles via Yahoo News· 5 hours agoATLANTA - The cost of diabetes medications is on the rise. In some cases, prices for insulin and new...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 15 hours agoThe drug is at the center of Novartis’ pending $2.9 billion acquisition of MorphoSys, but there are questions about its safety after a Stat report...